
Rx Rundown: Merck, Novo Nordisk, GSK and more
Deals: Merck signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion. Clover Biopharmaceuticals said Gavi sent notice of the termination of their vaccine deal and is demanding the return of a $224 …